相似文献
1
RNA-based drugs and vaccines.
Expert Rev Vaccines. 2015 Feb;14(2):253-63. doi: 10.1586/14760584.2015.959932. Epub 2014 Sep 14.
2
Current progress of DNA vaccine studies in humans.
Expert Rev Vaccines. 2008 Mar;7(2):175-91. doi: 10.1586/14760584.7.2.175.
3
DNA vaccines 2014 meeting: Highlights and overview.
Hum Vaccin Immunother. 2015;11(8):1887-8. doi: 10.1080/21645515.2015.1066947.
4
Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
Vaccine. 2007 Sep 27;25 Suppl 2:B24-34. doi: 10.1016/j.vaccine.2007.05.030. Epub 2007 Jun 6.
5
DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
Expert Rev Vaccines. 2008 Sep;7(7):1085-101. doi: 10.1586/14760584.7.7.1085.
6
Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.
Infect Immun. 2004 Nov;72(11):6418-25. doi: 10.1128/IAI.72.11.6418-6425.2004.
7
Technologies for enhanced efficacy of DNA vaccines.
Expert Rev Vaccines. 2012 Feb;11(2):189-209. doi: 10.1586/erv.11.188.
8
Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life and intracellular targeting strategies with a strategy to boost CD4+ T cell.
Hum Gene Ther. 2007 Nov;18(11):1129-39. doi: 10.1089/hum.2007.090.
9
Recent advances in design of immunogenic and effective naked DNA vaccines against cancer.
Recent Pat Anticancer Drug Discov. 2014 Jan;9(1):66-82. doi: 10.2174/1574891x113089990037.
10
Improvement of different vaccine delivery systems for cancer therapy.
Mol Cancer. 2011 Jan 7;10:3. doi: 10.1186/1476-4598-10-3.
引用本文的文献
1
Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems.
Med Oncol. 2025 Mar 17;42(4):113. doi: 10.1007/s12032-025-02670-z.
2
A Review of Clinical Trials of Cancer and Its Treatment as a Vaccine.
Rev Recent Clin Trials. 2024;19(1):7-33. doi: 10.2174/0115748871260733231031081921.
3
Research progress on non-protein-targeted drugs for cancer therapy.
J Exp Clin Cancer Res. 2023 Mar 14;42(1):62. doi: 10.1186/s13046-023-02635-y.
4
DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery.
Sci Rep. 2022 Jun 7;12(1):9394. doi: 10.1038/s41598-022-12100-z.
5
MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2.
Noncoding RNA. 2021 Feb 18;7(1):14. doi: 10.3390/ncrna7010014.
6
Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies.
Molecules. 2019 Dec 17;24(24):4620. doi: 10.3390/molecules24244620.
7
The CRISPR-Cas13a Gene-Editing System Induces Collateral Cleavage of RNA in Glioma Cells.
Adv Sci (Weinh). 2019 Aug 29;6(20):1901299. doi: 10.1002/advs.201901299. eCollection 2019 Oct 16.
8
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity.
Mol Ther. 2020 Jan 8;28(1):119-128. doi: 10.1016/j.ymthe.2019.09.009. Epub 2019 Sep 12.
9
Latest development on RNA-based drugs and vaccines.
Future Sci OA. 2018 May 4;4(5):FSO300. doi: 10.4155/fsoa-2017-0151. eCollection 2018 Jun.
10
Trial watch: DNA-based vaccines for oncological indications.
Oncoimmunology. 2017 Nov 20;6(12):e1398878. doi: 10.1080/2162402X.2017.1398878. eCollection 2017.
本文引用的文献
1
MicroRNA binding site polymorphisms as biomarkers in cancer management and research.
Pharmgenomics Pers Med. 2014 Jul 23;7:173-91. doi: 10.2147/PGPM.S61693. eCollection 2014.
2
Panel of five microRNAs as potential biomarkers for the diagnosis and assessment of male infertility.
Fertil Steril. 2014 Oct;102(4):989-997.e1. doi: 10.1016/j.fertnstert.2014.07.001. Epub 2014 Aug 6.
3
Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS.
Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1545-52. doi: 10.2215/CJN.11561113. Epub 2014 Aug 8.
4
Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease.
Clin Respir J. 2016 Jan;10(1):104-11. doi: 10.1111/crj.12194. Epub 2014 Sep 4.
5
The potential of miRNAs as biomarkers for multiple myeloma.
Expert Rev Mol Diagn. 2014 Nov;14(8):947-59. doi: 10.1586/14737159.2014.946906. Epub 2014 Aug 7.
6
MicroRNAs as potential diagnostic biomarkers in renal cell carcinoma.
Tumour Biol. 2014 Nov;35(11):11041-50. doi: 10.1007/s13277-014-2381-3. Epub 2014 Aug 6.
7
Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy.
Front Oncol. 2014 Jun 13;4:141. doi: 10.3389/fonc.2014.00141. eCollection 2014.
8
Alphavirus-based vaccines.
Viruses. 2014 Jun 16;6(6):2392-415. doi: 10.3390/v6062392.
9
Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
Biomaterials. 2014 Aug;35(26):7622-34. doi: 10.1016/j.biomaterials.2014.05.050. Epub 2014 Jun 11.
10
Epigenetically regulated microRNAs and their prospect in cancer diagnosis.
Expert Rev Mol Diagn. 2014 Jul;14(6):673-83. doi: 10.1586/14737159.2014.925399. Epub 2014 Jun 10.
Zotero 插件